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Previewsdifference between sensitive and resis-
tant clones. Additionally, when profiled,
none of the cladosporin-resistant clones
displayed crossresistance to other anti-
malarial drugs. Taken together, these
data point toward PfKrs1 being the unique
target of cladosporin. In subsequent test-
ing, cladosporin directly inhibited PfKrs1
in a biochemical assay but was only
weakly active toward its human counter-
part. This suggests that the cellular selec-
tivity arises mechanistically, making this
protein an attractive target for drug dis-
covery. Examining the homology model
using in silico docking suggested that cla-
dosporin might bind the ATP binding
pocket of PfKrs1; this hypothesis was
confirmed by direct competition between
cladosporin and ATP. Additionally, key
residues responsible for cladosporin
selectivity and specificity were identified
and further validated in yeast growth
assays. Finally, cladosporin was shown
to block de novo protein biosynthesis in
P. falciparum in a metabolic labeling
assay, as would be expected.
While the authors conservatively don’t
claim PfKrs1 as the only target of clado-sporin, the body of evidence they present
strongly points to PfKrs1 being the main
target of cladosporin. The target identifi-
cation strategy applied here illustrates
a successful case in which the target for
a compound identified in a phenotypic
screen can be successfully defined using
a combination of genetic and biochemical
approaches. On a broader view, these
findings validate the amino-tRNA synthe-
tases as drug targets for malaria and
potentially in related parasitic diseases
(toxoplasma, leishmania, and trypano-
some). The essential role of this target in
both liver and blood stages of malaria
represents a tremendous opportunity for
the discovery of the next generation of
antimalarials.REFERENCES
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Our view of the response to infection is limited by currentmethodologies, which provideminimal spatial infor-
mation on the systemic inflammatory response. In this issue, Attia et al. (2012) describe a cutting-edge
approach to image the inflammatory response to infection, which includes identification of host proteins in
three dimensions.The host inflammatory response to infec-
tion is a complex and highly orchestrated
process critical for defense against in-
vading microorganisms. On a molecular
and cellular level, the inflammatory re-
sponse involves acute phase proteins,
cytokines, chemokines, and other mole-
cules produced locally by activated or
damaged host cells, and many leukocyte
subsets, including T cells, mononuclearphagocytes,andgranulocytes.The inflam-
matory response is typically localized to
the infected tissues, but there are systemic
changes in host molecules, and multiple
organs can be infected. A comprehensive
understanding of the host response to
infection is an important step toward
development of therapeutic interventions
designed to treat and/or moderate the
severity of bacterial infections.There are numerous methods used
to evaluate the systemic inflammatory
response, including diagnostic hema-
tology and clinical chemistry analyses,
ELISA and Multiplex Luminex-based
assays, which can be used to quantitate
chemokine and cytokine levels, and flow
cytometry for characterization of leuko-
cytes. Such assays are typically per-
formed with blood or serum samples11, June 14, 2012 ª2012 Elsevier Inc. 557
Table 1. Comparison of Selected Methods Used to Evaluate the Inflammatory Response
Throughput Sensitivity Spatial Detail Real Time Whole Animal Discovery In Vivo
Flow cytometry ++ +++     
Expression microarrays +++ +++    +++ 
Two-dimensional proteomics +++ +++    +++ 
Cytokine profiling ++ ++     
Two-photon intravital microscopy ++ ++ ++ +++ +++  +++
Bioluminescence imaging + ++ ++ +++ +++  +++
Bioluminescence tomography/MR + ++ +++ + +++  +++
MALDI IMS/MRI + + +++  +++ +++ +++
, not applicable; +, low; ++, moderate; +++, high.
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Previewsfrom patients and can provide informa-
tion important for patient care. These
approaches, along with other standard
methods, such as immunofluorescence
microscopy, histopathology, and immu-
nohistochemistry, are also used to inves-
tigate localized inflammatory responses
to infection, although these latter
methods require tissues obtained from
the site of infection. Flow cytometry and
histopathology are especially useful for
identification of leukocyte subsets (e.g.,
monocytes and neutrophils) that are char-
acteristic of acute inflammation caused
by bacterial infection (Table 1).
Two-photon intravital microscopy
(Peters et al., 2008), which is the applica-
tion of confocal laser-scanning micros-
copy to live animals, and in vivo biolumi-
nescence imaging (Contag et al., 1995;
Hardy et al., 2004)—a method that uti-
lizes luminescence reporter molecules—
provide information about the inflamma-
tory response and infection process in
live animals. These approaches have the
ability to provide real-time data on cellular
processes that are essential for the host
response to infection, although they are
not uniquely optimal for spatial resolution
of the infection process (Table 1). To that
end, recent studies have combined (core-
gistered) bioluminescence imaging with
a second imaging modality, such as mi-
crocomputed tomography or magnetic
resonance, which provide detailed struc-
tural information about internal organs
and tissues, to generate a three-dimen-
sional (3D) rendering of the infection
process and tissues of interest (Beattie
et al., 2009; Cronin et al., 2012). This
combined imaging approach provides
good spatial resolution of the pathologic
process of interest, but the major limita-
tion of these methods is that they require558 Cell Host & Microbe 11, June 14, 2012 ªspecific tools and reagents (e.g., trans-
genic mice expressing fluorescent or
luminescent reporters in specific genes
and genetically engineered biolumines-
cent bacteria) that often must be gener-
ated de novo.
By comparison, matrix-assisted laser
desorption/ionization imagingmass spec-
trometry (MALDI IMS) can be used as
a discovery-based approach to identify
proteins in the absence of specific anti-
body or other reagents (Seeley and Cap-
rioli, 2008). Indeed, Corbin et al. used
MALDI IMS to identify calprotectin, an
antimicrobial protein produced by neutro-
phils, as a host protein abundant within
Staphylococcus aureus abscesses in
mice (Corbin et al., 2008), a finding impor-
tant for our understanding of the innate
immune response to bacterial infection.
Although MALDI IMS alone can provide
spatial resolution of proteins in host
organs and tissues, some information is
lost during sample preparation and anal-
ysis (Sinha et al., 2008). To solve this
problem, the discovery-based capability
of MALDI IMS can be combined with
in vivo magnetic resonance imaging
(MRI) to provide highly accurate 3D
rendering of proteins in tissues, including
spatial distribution of proteins in intact
animals (Sinha et al., 2008). This approach
is currently being used for the study of
proteins and peptides associated with
tumors or present in specific cancer
tissues, but it has not been applied to the
study of the inflammatory response to
bacterial infection until now.
In this issue of Cell Host & Microbe,
Attia et al. (2012) vetted the combined
application of MALDI IMS and MRI as
a method to provide spatial detail of the
host inflammatory response in a whole
organism during systemic infection with2012 Elsevier Inc.Staphylococcus aureus, a bacterial path-
ogen that is a prominent cause of human
disease. One of the hallmarks of dissemi-
nated S. aureus disease is the develop-
ment of multiple focal abscesses that
manifest primarily in the kidneys in
a mouse model of infection. To gain
insight into the host immune response
to S. aureus systemic disease, Attia and
colleagues performed MALDI IMS on
sagittal sections of S. aureus-infected
mice and compared the results to mock-
infected controls. MALDI IMS revealed
the presence of proteins such as alpha-
globin (m/z 5,020), a protein found in the
kidney cortex, that were conserved in in-
fected and uninfected animals. Notably,
MALDI IMS revealed the identity and
distribution of proteins that increased in
abundance in response toS. aureus infec-
tion. For example, the mass signal corre-
sponding to the calgranulin A subunit of
calprotectin (m/z 10,165) was most abun-
dant at kidney abscess sites, a finding
consistent with a previous report (Corbin
et al., 2008). In addition, MALDI IMS de-
tected the presence of two unmasked
proteins (m/z 10,202 and m/z 10,369)
that increased in abundance within a
S. aureus abscess. As discussed above,
although MALDI IMS is a powerful tech-
nique for proteomic analysis and affords
limited spatial resolution, the accuracy of
3D reconstruction can be vastly improved
through integration with high-resolution
MRI images. The advanced integrated
imaging technique was used by Attia
et al. to demonstrate that alpha-globin
was excluded from the abscess, whereas
calprotectin was localized precisely at the
site of abscess formation. Importantly,
these findings serve as model proof
of concept of the utility of MALDI IMS
and MRI for imaging the host/pathogen
Cell Host & Microbe
Previewsinterface and highlight the potential for
use in discovery-based infectious disease
research.
The MALDI IMS/MRI approach is
a tremendous advance for infectious
disease research, since proteins can be
identified and localized in 3D space
without specific reagents or previous
knowledge that they are present at the
site of infection. As with all new technolo-
gies, there are a few drawbacks to the
method that will need to be addressed
as the technology progresses. For
example, it will be important to develop
the capacity to identify proteins pro-
duced by the infecting bacterial path-
ogen. Such capacity would be poten-
tially informative for design of new
vaccines or therapeutics. The inability to
detect pathogen proteins may simply be
a limitation of the sensitivity of the current
instrumentation, as suggested by Seeley
and Caprioli (2008). Although the MALDIIMS/MRI approach is currently limited
to animal infection models, the ability to
perform in vivo imaging and protein
identification in humans would certainly
enhance our understanding of bacterial
diseases. Future advances in imaging
methodologies will likely enable this
capacity.
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